Eight existing contexts were assessed from five primary reference groups, with a complete assessment of the already-qualified 2018 correction added. Seven are retained as core annotations and broad precursor/energy metabolism as non-core. All source objects, original reference identities/findings and seven splice products are preserved; no new annotation or quotation is added.
The 2024 CoQ paper directly resolves an electron-supply role using reconstructed tetrapod-ancestral proteins. The retained human claim therefore keeps an explicit conservation boundary. The 1988 human paper was recovered as all five original scanned pages and read completely; its splice-form discussion leaves functional differences unresolved. The older mapping paper remains abstract-only, and its steroid claim is supported at the same gene-level by independently read pathway evidence rather than a fabricated assay.
Exact original MitoCoP accession joins support mitochondrial enrichment, and human fibroblast imaging independently supports mitochondrial location with additional extramitochondrial signal. The 2018 corrigendum changes three Figure 1 genotype labels and does not state a localization correction.
See the source guide, source-keyed decisions and original target records for source boundaries. Genuine provider failures and the oversized unavailable PAINT normal are preserved in the accepted intake. No failed provider output has been replaced with authored content or used as an invented citation.
The genuine original and repository normal for PMID:38885337 were acquired after explicit source-ownership qualification. Bounded reading adds human patient-derived adrenal-like cell steroid-output and male-mouse context to the existing steroid-biosynthesis assessment. Direct electron supply, measured downstream steroid profiles and proposed secondary redox effects remain separate claims. No new annotation or product is proposed.